JPWO2021033247A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021033247A5
JPWO2021033247A5 JP2021541368A JP2021541368A JPWO2021033247A5 JP WO2021033247 A5 JPWO2021033247 A5 JP WO2021033247A5 JP 2021541368 A JP2021541368 A JP 2021541368A JP 2021541368 A JP2021541368 A JP 2021541368A JP WO2021033247 A5 JPWO2021033247 A5 JP WO2021033247A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
macrophages
cell population
composition according
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021541368A
Other languages
English (en)
Japanese (ja)
Other versions
JP7500083B2 (ja
JPWO2021033247A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/032322 external-priority patent/WO2021033247A1/ja
Publication of JPWO2021033247A1 publication Critical patent/JPWO2021033247A1/ja
Publication of JPWO2021033247A5 publication Critical patent/JPWO2021033247A5/ja
Application granted granted Critical
Publication of JP7500083B2 publication Critical patent/JP7500083B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021541368A 2019-08-19 2019-08-19 細胞含有医薬組成物 Active JP7500083B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/032322 WO2021033247A1 (ja) 2019-08-19 2019-08-19 細胞含有医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2021033247A1 JPWO2021033247A1 (cg-RX-API-DMAC7.html) 2021-02-25
JPWO2021033247A5 true JPWO2021033247A5 (cg-RX-API-DMAC7.html) 2022-08-26
JP7500083B2 JP7500083B2 (ja) 2024-06-17

Family

ID=74659865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021541368A Active JP7500083B2 (ja) 2019-08-19 2019-08-19 細胞含有医薬組成物

Country Status (4)

Country Link
US (1) US12460182B2 (cg-RX-API-DMAC7.html)
JP (1) JP7500083B2 (cg-RX-API-DMAC7.html)
KR (1) KR102791419B1 (cg-RX-API-DMAC7.html)
WO (1) WO2021033247A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Clio 心筋梗塞の修復再生を誘導する多能性幹細胞
WO2014051154A1 (ja) 2012-09-28 2014-04-03 公益財団法人先端医療振興財団 虚血性疾患治療に適した細胞を含む細胞群の生体外増幅方法
AU2015297347B2 (en) 2014-08-01 2021-05-27 PuREC Co., Ltd Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
US20160287638A1 (en) 2015-04-02 2016-10-06 Stemedica Cell Technologies, Inc. Ischemic tolerant cells and cellular factors in the treatment of peripheral artery disease
EP3297615A1 (en) * 2015-05-20 2018-03-28 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical composition for modulation polarization and activation of macrophages
EP3299453B1 (en) * 2016-09-23 2019-05-08 Xcell Medical Solutions, S.L. Cell therapy with polarized macrophages for tissue regeneration

Similar Documents

Publication Publication Date Title
Sarsenova et al. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
He et al. miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson’s disease model via regulation of Nox4/ROS/Nrf2 signaling
Ionescu et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action
Liu et al. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
Pistoia et al. Mesenchymal stromal cells and autoimmunity
Li et al. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia
Godoy et al. Clinical translation of mesenchymal stromal cell therapy for graft versus host disease
Samper et al. Cardiac cell therapy: boosting mesenchymal stem cells effects
JP2020089373A (ja) 幹細胞培養培地及び細胞生存を増強する方法
Budgude et al. Mesenchymal stromal cell‐derived extracellular vesicles as cell‐free biologics for the ex vivo expansion of hematopoietic stem cells
ES3036762T3 (en) A modulatable switch for selection of donor modified cells
KR20150020113A (ko) mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
Chen et al. Recent advances in the role of mesenchymal stem cells as modulators in autoinflammatory diseases
Vandermeulen et al. Rationale for the potential use of mesenchymal stromal cells in liver transplantation
CA3115291A1 (en) Methods for the expansion of mesenchymal stromal cells
Silva et al. Granulocyte-colony stimulating factor-overexpressing mesenchymal stem cells exhibit enhanced immunomodulatory actions through the recruitment of suppressor cells in experimental chagas disease cardiomyopathy
Ringdén et al. Mesenchymal stromal cells in pediatric hematopoietic cell transplantation a review and a pilot study in children treated with decidua stromal cells for acute graft-versus-host disease
Hamzic et al. Interleukin-6 primarily produced by non-hematopoietic cells mediates the lipopolysaccharide-induced febrile response
Wang et al. Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study
Suresh et al. Exploring MSC and HSPC interactions: new frontiers in hematopoiesis and transplant medicine
Sadeghi et al. Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo
Zhang et al. Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis
Ringdén et al. Successful reversal of acute lung injury using placenta-derived decidual stromal cells
US20220331359A1 (en) Purified double negative t cell and preparation and use thereof
Han et al. The use of normal stem cells and cancer stem cells for potential anti-cancer therapeutic strategy